February 2024
1. HAN P, Lin W, Fan H, Tong Y, et al
   Characterization of phage evolution and phage resistance in drug-resistant Stenotrophomonas maltophilia.
   J Virol. 2024;98:e0124923.
   

   >> Share

   
   January 2024
2. TAN X, Chen K, Jiang Z, Liu Z, et al
   Evaluation of the impact of repeated intravenous phage doses on mammalian host-phage interactions.
   J Virol. 2024;98:e0135923.
   

   >> Share

   
   July 2023
3. HICKERSON BT, Petrovskaya SN, Dickensheets H, Donnelly RP, et al
   Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility.
   J Virol. 2023 Jul 5:e0015423. doi: 10.1128/jvi.00154.
   

   >> Share

   
   May 2023
4. DEKKER JG, Klaver B, Berkhout B, Das AT, et al
   HIV-1 3'-Polypurine Tract Mutations Confer Dolutegravir Resistance by Switching to an Integration-Independent Replication Mechanism via 1-LTR Circles.
   J Virol. 2023 May 1:e0036123. doi: 10.1128/jvi.00361.
   

   >> Share

   
   August 2022
5. JIAO Z, Yan Y, Chen Y, Wang G, et al
   Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors.
   J Virol. 2022 Aug 24:e0090722. doi: 10.1128/jvi.00907.
   

   >> Share

   
   
6. FARRUKEE R, Gunalan V, Maurer-Stroh S, Reading PC, et al
   Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.
   J Virol. 2022;96:e0091822.
   

   >> Share

   
   June 2022
7. RICHETTA C, Subra F, Malet I, Leh H, et al
   Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration.
   J Virol. 2022 Jun 27:e0067622. doi: 10.1128/jvi.00676.
   

   >> Share

   
   March 2022
8. JIANG L, Samant N, Liu P, Somasundaran M, et al
   Identification of a Permissive Secondary Mutation That Restores the Enzymatic Activity of Oseltamivir Resistance Mutation H275Y.
   J Virol. 2022;96:e0198221.
   

   >> Share

   
   January 2022
9. 
   Articles of Significant Interest In This Issue.
   J Virol. 2022;96:e0199121.
   

   >> Share

   
   
10. MURER L, Petkidis A, Vallet T, Vignuzzi M, et al
    Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating.
    J Virol. 2022;96:e0106021.
    

    >> Share

    
    November 2021
11. KHATUN M, Kumar K, Baidya A, Mondal RK, et al
    Variability in the response of HBV D-subgenotypes to antiviral therapy: designing pan D-subgenotypic reverse transcriptase inhibitors.
    J Virol. 2021 Nov 3:JVI0180021. doi: 10.1128/JVI.01800.
    

    >> Share

    
    September 2021
12. LEVINE CB, Mire CE, Geisbert TW
    Comparison of Zaire and Bundibugyo Ebolavirus Polymerase Complexes and Susceptibility to Antivirals through a Newly Developed Bundibugyo Minigenome System.
    J Virol. 2021;95:e0064321.
    

    >> Share

    
    June 2021
13. NAKAJIMA S, Watashi K, Kato T, Muramatsu M, et al
    Biochemical and structural properties of entecavir-resistant hepatitis B virus polymerase with L180M/M204V mutations.
    J Virol. 2021 Jun 2:JVI0240120. doi: 10.1128/JVI.02401.
    

    >> Share

    
    May 2021
14. WALTER M, Perrone R, Verdin E
    Targeting conserved sequences circumvents the evolution of resistance in a viral gene drive against human cytomegalovirus.
    J Virol. 2021 May 19. pii: JVI.00802-21. doi: 10.1128/JVI.00802.
    

    >> Share

    
    April 2021
15. MORI K, Ohniwa RL, Takizawa N, Naito T, et al
    Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain using an Engineered High-Fidelity Viral Polymerase.
    J Virol. 2021 Apr 7. pii: JVI.00493-21. doi: 10.1128/JVI.00493.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share